or Try an Advanced Search...

    Resistant Prostate Cancer Stocks List

    Symbol Grade Name % Change
    EXEL A Exelixis, Inc. 0.00
    CRDF B Cardiff Oncology, Inc. 0.00
    AMGN C Amgen Inc. 0.00
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major
    Related Stock Lists: Prostate Cancer Biotechnology Cancer Drugs Medicine Metastatic Castration Resistant Prostate Cancer Acute Myeloid Leukemia Adenosine Advanced Solid Tumors Antineoplastic Drugs Blood Cells Bone Bone Disease Cancer Care Cancer Treatment Chemotherapy Clinic Clinical Medicine Colorectal Cancer Cyclopropanes

    Related ETFs - A few ETFs which own one or more of the above listed Resistant Prostate Cancer stocks.

    Symbol Grade Name Weight
    BBH D Market Vectors Biotech ETF 14.82
    IBB D iShares Nasdaq Biotechnology Index Fund 9.19
    IBBQ D Invesco Nasdaq Biotechnology ETF 9.16
    BIS A ProShares UltraShort Nasdaq Biotechnology 8.87
    PBE D PowerShares Dynamic Biotech & Genome 8.09
    View all Resistant Prostate Cancer ETFs...
    Compare ETFs
    Compare BBH to IBB Compare BBH to PBE Compare IBB to IBBQ

        Resistant Prostate Cancer Stocks Recent News

        Date Stock Title
        Apr 22 AMGN 10 Best Performing Biotech ETFs in 2024
        Apr 17 EXEL Institutional investors in Exelixis, Inc. (NASDAQ:EXEL) lost 3.8% last week but have reaped the benefits of longer-term growth
        Apr 17 AMGN Visa To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
        Apr 17 AMGN Can This High-Yield Dividend Stock Keep Beating the S&P 500?
        Apr 17 AMGN Got $5,000? Here Are 3 Undervalued Stocks to Buy and Hold Forever
        Apr 16 AMGN AMGEN TO PRESENT TEZSPIRE® PHASE 2A COPD DATA AT ATS 2024
        Apr 16 AMGN The 3 Best Biotech Stocks to Buy Now: Q2 Edition
        Apr 16 EXEL Exelixis to Release First Quarter 2024 Financial Results on Tuesday, April 30, 2024
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major
        Related Stock Lists: Prostate Cancer Biotechnology Cancer Drugs Medicine Metastatic Castration Resistant Prostate Cancer Acute Myeloid Leukemia Adenosine Advanced Solid Tumors Antineoplastic Drugs Blood Cells Bone Bone Disease Cancer Care Cancer Treatment Chemotherapy Clinic Clinical Medicine Colorectal Cancer Cyclopropanes
        Resistant Prostate Cancer

        Resistant prostate cancer is a type of prostate cancer that has become resistant to hormone therapy, which is the most common form of treatment for prostate cancer. This type of cancer is more difficult to treat and may require more aggressive treatments such as chemotherapy or radiation therapy.

        Browse All Tags